Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Pharmaceuticals market research, reports and industry analysis

mail

Contact us for professional industry advice

Email us or call

+44(0)20 7936 6830
mail

for FREE research alerts
to your inbox

10 Item(s)

Page 1 of 1

  1. Pharmaceutical Industry Business Confidence Report H2 2016

    By: Kable
    , Published: Aug-2016
    , Product code: KG6250PR
    The existing economic environment is stable for the pharmaceutical industry, and customer confidence levels will remain constant in H2 2016 (July 2016–December 2016). Companies are slightly optimistic about economic conditions in North America and the Asia-Pacific due to positive momentum in the US, firm domestic demand, and strong government expenditure in India. The pharmaceutical industry is expected to record higher expenditure towards new product development and mergers and acquisitions in H2 2016 as compared to H1 2016. Moreover, executives with business operations in the Asia-Pacific and Europe expect increase in raw material prices in H2 2016 as compared to H1 2016.
    $1,950.00

  2. Pharmaceutical Industry Business Outlook and Procurement Report H1 2016

    By: Kable
    , Published: Apr-2016
    , Product code: KG6230PR
    The key priorities forecast in the business structure for global pharmaceutical industry executives in H1 2016 (April–September 2016) are new product development and improving operational efficiency. China, India, and Brazil are the leading emerging markets that are expected to offer the most opportunities for global pharmaceutical industry growth in H1 2016. Market uncertainty and rising competition are the immediate business concerns for global pharmaceutical industry executives. The gradual slowdown and restructuring of economic activity in China and tightening of the monetary policy in the US are creating a major concern for the pharmaceutical industry. Packaging equipment is expected to offer significant growth opportunities within the pharmaceutical industry in Asia-Pacific. Avoidance of counterfeiting and provision of longer shelf life are identified as the key drivers for pharmaceutical packaging companies to witness significant business opportunities within the Asia-Pacific region.
    $1,950.00

  3. Pharmaceutical Industry Business Confidence Report H1 2016

    By: Kable
    , Published: Mar-2016
    , Product code: KG6220PR
    The existing economic environment is stable for the pharmaceutical industry, and customer confidence levels will remain constant in H1 2016 (January 2016–June 2016). Companies are slightly optimistic about economic conditions in North America and Asia-Pacific due to positive momentum in the US manufacturing and production sectors, firm domestic demand, strong government expenditure in India, and robust private consumption and export growth in South Korea and Vietnam. Over the next six months the industry will increase its expenditure towards new product development and IT infrastructure. Moreover, companies operating in Asia-Pacific forecast their budget allocation for pharmaceutical equipment to increase significantly in 2016, compared to 2015.
    $1,950.00

  4. Pharmaceutical Industry Business Confidence Report H1 2015

    By: Kable
    , Published: Feb-2015
    , Product code: KG4410PR
    “Pharmaceutical Industry Business Confidence Report H1 2015” is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the pharmaceutical industry. This report also examines executive opinions with regards to the current and future state of the economy and its effect on the industry. It analyzes the likely effect of supplier price changes, sales performance, and staff headcount within the industry over January–June 2015. This report provides an overview of the key priorities, threats, and opportunities for the global pharmaceutical industry over January–June 2015. Furthermore, the survey forecasts projected investment on pharmaceutical equipment, procurement budget allocations and the leading suppliers of equipment in the pharmaceutical industry.
    $1,950.00

  5. Pharmaceutical Business Confidence Report Q4 2014

    By: Kable
    , Published: Nov-2014
    , Product code: KG4330PR
    “Pharmaceutical Business Confidence Report Q4 2014” is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the pharmaceutical industry over October–December 2014. This report also examines executive opinions with regards to the current and future state of the economy and its effect on the industry. It analyzes the likely effect of supplier price changes, sales performance, and staff headcount within the industry. Furthermore, this report provides an overview of the key priorities, threats, and opportunities for the global pharmaceutical industry. In addition, the report includes the forecasts of the projected investments on pharmaceutical equipment, procurement budget allocations and the leading suppliers of pharmaceutical equipment in the pharmaceutical industry.
    $1,950.00

  6. Pharmaceutical Business Confidence Report Q3 2014

    By: Kable
    , Published: Oct-2014
    , Product code: KG4260PR
    "Pharmaceutical Business Confidence Report Q3 2014” is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the pharmaceutical industry. This report also examines executive opinion with regards to the current and future state of the economy and its retrospective effect on the industry. It analyzes the likely effect of supplier price changes, sales performance, and staff headcount within the industry over July–September 2014. In addition, it provides an overview of the key priorities, threats, and opportunities for the global pharmaceutical industry over July–September 2014.
    $1,950.00

  7. Pharmaceutical Business Confidence Report Q1 2014

    By: Kable
    , Published: Jan-2014
    , Product code: KG4020PR-
    “Pharmaceutical Business Confidence Report Q1 2014” is a new report by Kable that analyzes pharmaceutical industry executives’ views on the global economy, expectations on customer confidence, supplier prices, key business concerns, and how executives’ future investments are set to change in Q1 2014. This report also gives you access to regional analysis of industry outlook, industry and company growth prospects, future opportunities, staff hiring, and sales performance. Apart from providing access to the opinions and strategies of global pharmaceutical industry executives, it also examines their actions surrounding business priorities, threats and opportunities, and future investment areas over the next six months. Moreover, this report provides a comparative analysis of survey results with Q4 2013 wherever applicable.
    $1,950.00

  8. Pharmaceutical Business Confidence Report Q4 2013

    By: Kable
    , Published: Nov-2013
    , Product code: KG3025PR-
    “Pharmaceutical Business Confidence Report Q4 2013” is a new report by Kable that analyzes pharmaceutical industry executives’ views on the global economy, expectations on consumer confidence, supplier prices, key business concerns, and how executives’ future investments are set to change in Q4 2013. This report also gives you access to regional analysis of industry outlook, industry and company growth prospects, future opportunities, staff hiring, and sales performance. Apart from providing access to the opinions and strategies of global pharmaceutical industry executives, it also examines their actions surrounding business priorities, threats and opportunities, and future investment areas over the next six months.
    $1,950.00

  9. Global Pharmaceutical Survey 2013–2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry

    By: ICD Research
    , Published: Feb-2013
    , Product code: PH2135PR-
    “Global Pharmaceutical Survey 2013–2014: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry” is a new report by ICD Research that analyzes how pharmaceutical industry companies’ procurement expenditures, business strategies, and practices are set to change in 2013–2014. Additionally, this report also presents comparative analysis between four years of survey results (wherever applicable). This report gives access to category-level spending outlooks, budgets, supplier selection criteria, business challenges, and investment opportunities of leading purchase decision makers. The report also identifies the future growth of buyers and suppliers, M&A, capital expenditure, staff hiring, and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities, as well as access to information categorized by region, company type, and size.
    $2,000.00

  10. Global Pharmaceutical Survey 2013–2014 - Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry

    By: ICD Research
    , Published: Feb-2013
    , Product code: PH2140PR-
    “Global Pharmaceutical Survey 2013–2014: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry” is a new report by ICD Research that analyzes how pharmaceutical industry companies’ media spend, marketing and sales strategies and practices, and business planning are set to change in 2013–2014. Additionally, this report also presents comparative analysis between four years of survey results (wherever applicable). This report provides the current size of the marketing and advertising budgets of global pharmaceutical industry suppliers and how spending by global pharmaceutical industry suppliers will change, providing an insight into global marketing behaviour. In addition, the report identifies future growth of global pharmaceutical industry buyers and suppliers and M&A activity. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and sizes.”
    $2,000.00

10 Item(s)

Page 1 of 1